HEALTH CARE DEVICE AND HEALTH CARE METHOD
20230317247 · 2023-10-05
Inventors
- MING-SHUN LEE (NEW TAIPEI CITY, TW)
- CHIN-SUNG TSENG (NEW TAIPEI CITY, TW)
- HSU-HUI TSENG (NEW TAIPEI CITY, TW)
- HSIEN-CHING TSENG (NEW TAIPEI CITY, TW)
- WEI-LONG LEE (NEW TAIPEI CITY, TW)
Cpc classification
International classification
Abstract
A health care device and health care method are illustrated. A health care device is used to emit a low-frequency wave of a predetermined frequency forward to an umbilicus of a user, wherein the low-frequency wave is emitted at a predetermined position, and the predetermined position is located in front of the umbilicus of the user with a predetermined distance. The health care device comprises the low-frequency wave emitter, a column and a cone. The predetermined frequency is within a range between 1.27 Hz and 1.81 Hz, and the predetermined distance D is within a range between 5 cm and 8 cm. The health care device and the health care method can increase the content of activated T cells in the blood, so as to achieve effects of convenient operation, accurate identification of the use position, non-invasive treatment, non-contact treatment, and no harm caused by excessive energy risk.
Claims
1. A health care device, comprising: a low-frequency wave emitter, configured to emit a low-frequency wave of a predetermined frequency; a column, having a top surface, a bottom surface and a column body which has two ends respectively connected to the top surface of the column and the bottom surface of the column; and a cone, having a vertex, a bottom surface and a cone body which has two ends respectively connected to the vertex and the bottom surface of the cone; wherein the top surface of the column is correspondingly jointed to the bottom surface of the cone, and the low-frequency wave emitter is connected to the bottom surface of column.
2. The health care device according to claim 1, wherein the predetermined frequency is within a range between 1.27 Hz and 1.8 Hz.
3. The health care device according to claim 2, wherein the predetermined frequency is 1.45 Hz.
4. The health care device according to claim 3, wherein the low-frequency wave emitter is a infrasound wave transducer, and the low-frequency wave is a infrasound wave.
5. The health care device according to claim 4, wherein the column is a cylinder, and the column and the cone are formed integrally.
6. The health care device according to claim 5, wherein the low-frequency wave emitter is connected to the bottom surface of the column via a tube.
7. The health care device according to claim 6, wherein the vertex further has a stick being vertically standing and having a longitudinal direction away from the bottom surface of the cone.
8. The health care device according to claim 7, wherein the longitudinal direction of the stick is coincided with a specific normal line of the bottom surface of the cone, and the specific normal line of the bottom surface of the cone passes through a bottom surface center of the cone.
9. A health care method, comprising: using a low-frequency wave emitter to emit a low-frequency wave of a predetermined frequency forward to an umbilicus of a user, wherein the low-frequency wave is emitted at a predetermined position, and the predetermined position is located in front of the umbilicus of the user with a predetermined distance.
10. The health care method according to claim 9, wherein the predetermined frequency is within a range between 1.27 Hz and 1.8 Hz.
11. The health care method according to claim 10, wherein the predetermined frequency is 1.45 Hz.
12. The health care method according to claim 11, wherein the low-frequency wave emitter is a infrasound wave transducer, and the low-frequency wave is a infrasound wave.
13. The health care method according to claim 12, wherein the predetermined position is located on a virtual bottom surface of a virtual cone, a virtual vertex of the virtual cone is the umbilicus, and the predetermined distance is within a range between 5 cm and 8 cm.
14. The health care method according to claim 13, wherein the predetermined position is located on a center of the virtual bottom surface.
15. The health care method according to claim 14, wherein the virtual cone is a circular cone, and the predetermined position is located on a circle center of the virtual bottom surface being a circle, and the predetermined distance is a distance between the circle center and the umbilicus.
16. A health care method, comprising: using a health care device to emit a low-frequency wave of a predetermined frequency forward to an umbilicus of a user, wherein the low-frequency wave is emitted at a predetermined position, and the predetermined position is located in front of the umbilicus of the user with a predetermined distance; wherein the health care device comprises: a low-frequency wave emitter, configured to emit a low-frequency wave of a predetermined frequency; a column, having a top surface, a bottom surface and a column body which has two ends respectively connected to the top surface of the column and the bottom surface of the column; and a cone, having a vertex, a bottom surface and a cone body which has two ends respectively connected to the vertex and the bottom surface of the cone; wherein the top surface of the column is correspondingly jointed to the bottom surface of the cone, and the low-frequency wave emitter is connected to the bottom surface of column.
17. The health care method according to claim 16, wherein the predetermined frequency is within a range between 1.27 Hz and 1.8 Hz.
18. The health care method according to claim 17, wherein the predetermined frequency is 1.45 Hz.
19. The health care method according to claim 18, wherein the low-frequency wave emitter is a infrasound wave transducer, and the low-frequency wave is a infrasound wave.
20. The health care method according to claim 19, wherein the predetermined position is located on a virtual bottom surface of a virtual cone, a virtual vertex of the virtual cone is the umbilicus, and the predetermined distance is within a range between 5 cm and 8 cm; the predetermined position is located on a center of the virtual bottom surface, the virtual cone is a circular cone, and the predetermined position is located on a circle center of the virtual bottom surface being a circle, the predetermined distance is a distance between the circle center and the umbilicus, and the vertex is located at the predetermined position.
21. The health care method according to claim 19, wherein the vertex further has a stick being vertically standing and having a longitudinal direction away from the bottom surface of the cone, the longitudinal direction of the stick is coincided with a specific normal line of the bottom surface of the cone and extending towards the umbilicus, the specific normal line of the bottom surface of the cone passes through a bottom surface center of the cone, and a stick tip of the stick is located at the predetermined position.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] The accompanying drawings are included to provide a further understanding of the present disclosure, and are incorporated in and constitute a part of this specification. The drawings illustrate exemplary embodiments of the present disclosure and, together with the description, serve to explain the principles of the present disclosure.
[0018]
[0019]
[0020]
[0021]
[0022]
[0023]
DESCRIPTION OF THE EXEMPLARY EMBODIMENTS
[0024] To understand the technical features, content and advantages of the present disclosure and its efficacy, the present disclosure will be described in detail with reference to the accompanying drawings. The drawings are for illustrative and auxiliary purposes only and may not necessarily be the true scale and precise configuration of the present disclosure. Therefore, the scope of the present disclosure should not be limited to the scale and configuration of the attached drawings.
[0025] Refer to
[0026] The low-frequency wave emitter 2 is preferably a infrasound wave transducer, and the low-frequency wave W can be a infrasound wave. The structure of the infrasound wave transducer comprises a power 21 and a vibration part 22. The vibration part 22 is electrically connected to the power 21. The vibration part 22 is a disc-shaped piezoelectric ceramic transducer. The piezoelectric ceramic transducer is made of piezoelectric material polarized in the thickness direction. The power 21 provides power to the vibration part 22 to make the vibration part 22 vibrates in the thickness direction to generate the infrasound wave of the predetermined frequency. In the present disclosure, the predetermined frequency is not larger than 1.81 Hz, or the predetermined frequency is not less than 1.27 Hz, or the predetermined frequency is within a range between 1.27 Hz and 1.81 Hz (p.s. the range comprises two end values of 1.27 Hz and 1.8 Hz). Preferably, the predetermined frequency is 1.45 Hz.
[0027] <Detection Manner and Effect>
[0028] The health care method is executed to personnel P and personnel Q, the predetermined distance D is selected to be 5 cm, the predetermined frequency is selected to be 1.45 Hz, and the low-frequency wave is selected to be the infrasound wave. The personnel P is a 74 years old man, the personnel Q is a 72 years old woman. Before executing the aforementioned health care method, blood samples are drawn from the personnel P and Q and sent to the medical laboratory for immunological examination to check the percentage (i.e. content) of active T cells. On the 19-th day after the execution of the aforementioned health care method for 2 hours, the blood sample of the personnel P is again taken and sent to the medical laboratory for immunological examination, and on the 42-nd day after the execution of the aforementioned health care method for 2 hours, the blood sample of the personnel Q is also taken again and sent to the medical laboratory for immunological examination. The percentages of active T cells of the blood samples are examined in the same way, and the results are recorded in TABLE 1 which is described later.
TABLE-US-00001 TABLE 1 PERSONNEL P PERSONNEL Q CHANGE RATE = CHANGE RATE = CONTENT OF ACTIVE CONTENT OF ACTIVE T CELLS AFTER T CELLS AFTER EXECUTION/CONTENT EXECUTION/CONTENT BEFORE AFTER OF ACTIVE T CELLS BEFORE AFTER OF ACTIVE T CELLS EXECUTION EXECUTION BEFORE EXECUTION EXECUTION EXECUTION BEFORE EXECUTION CONTENT 6.2% 12.8% 206.5% 5.3% 7.9% 149% OF ACTIVE T CELLS
[0029] From TABLE 1, before executing the aforementioned health care method, the content of active T cells in personnel P is 6.2%, and after executing the aforementioned health care method, the content of active T cells increased to 12.8%, and the change rate is 206.5%, that is, the content of active T cells is increased 106.5%. Before executing the aforementioned health care method, the content of active T cells in personnel Q is 5.3%, and after executing the aforementioned health care method, the content of active T cells is increased to 7.9%, and the change rate is 149%, that is, the content of active T cells is increased 49%. Therefore, the health care method provided by the present disclosure can promote the proliferation of active T cells, and as long as a single execution of 2 hours can make the content of active T cells increase, even after 42 days, still can maintain 49% increase quantity. Apparently, the health care method of the present disclosure is highly effective and can maintain long-term health effects.
[0030] Refer to
[0031] The low-frequency wave emitter 2 is connected with the bottom surface 32 of the column 3, preferably this low-frequency wave emitter 2 is directly connected with the bottom surface 32 of the column 3, such as this low-frequency wave emitter 2 is welded or screwed to the bottom surface 32 of the column 3, so when the power 21 is activated, the vibration part 22 will generate the low-frequency wave W of the predetermined frequency (please refer to
[0032] Refer to
[0033] Refer to
[0034] Refer to
[0035] The above-mentioned descriptions represent merely the exemplary embodiment of the present disclosure, without any intention to limit the scope of the present disclosure thereto. Various equivalent changes, alternations or modifications based on the claims of present disclosure are all consequently viewed as being embraced by the scope of the present disclosure.